Franklin Resources’s Tenaya Therapeutics TNYA Stock Holding History

Franklin Resources’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-21,692	Closed	-$127K	–	2782
2023 Q2	$127K	Buy	+21,692	New	+$126K	﹤0.01%	2492

Other funds holding TNYA

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Franklin Resources's TNYA Position: Q3 2023 in Review

Franklin Resources sold out of Tenaya Therapeutics (TNYA) in Q3 2023, closing a stake of 21,692 shares — an estimated $127K sold.

Franklin Resources first reported a position in TNYA in Q2 2023 and held it in 1 quarter. The position peaked at $127K in Q2 2023. 76 funds tracked by Wall St. Rank hold TNYA as of Q3 2023.

Franklin Resources reported no remaining Tenaya Therapeutics position as of Q3 2023 after selling out during the quarter.
Franklin Resources sold 21,692 Tenaya Therapeutics shares in Q3 2023, an estimated $127K.
Franklin Resources first reported a position in Tenaya Therapeutics in Q2 2023 and held it in 1 quarter.
Franklin Resources's Tenaya Therapeutics position peaked at $127K in Q2 2023.
76 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2023.

Based on Franklin Resources's 13F filing for Q3 2023, filed 13 Nov 2023.